Literature DB >> 13650489

Early activity in sporozoite-induced Plasmodium falciparum infections.

G M JEFFERY, M D YOUNG, R W BURGESS, D E EYLES.   

Abstract

Entities:  

Keywords:  MALARIA/experimental

Mesh：

Year:  1959        PMID： 13650489     DOI： 10.1080/00034983.1959.11685899

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  11 in total

1.  [RESEARCH ON THE INFECTIVE CAPACITY FOR A. ATROPARVUS, OF ASYMPTOMATIC P. VIVAX, P. FALCIPARUM AND P. MALARIAE PARASITEMIAS].

Authors:  M CIUCA; G LUPASCO; E NEGULICI; P CONSTANTINESCO; A CRISTESCO; I SANDESCO
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

Review 2.  Experimental human challenge infections can accelerate clinical malaria vaccine development.

Authors:  Robert W Sauerwein; Meta Roestenberg; Vasee S Moorthy
Journal:  Nat Rev Immunol       Date:  2011-01       Impact factor: 53.106

3.  Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy.

Authors:  J R Murphy; D F Clyde; D A Herrington; S Baqar; J R Davis; K Palmer; J Cortese
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

4.  Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial.

Authors:  Kirsten E Lyke; Matthew Laurens; Matthew Adams; Peter F Billingsley; Adam Richman; Mark Loyevsky; Sumana Chakravarty; Christopher V Plowe; B Kim Lee Sim; Robert Edelman; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

5.  Development of a new version of the Liverpool Malaria Model. I. Refining the parameter settings and mathematical formulation of basic processes based on a literature review.

Authors:  Volker Ermert; Andreas H Fink; Anne E Jones; Andrew P Morse
Journal:  Malar J       Date:  2011-02-11       Impact factor: 2.979

6.  Comparison of clinical and parasitological data from controlled human malaria infection trials.

Authors:  Meta Roestenberg; Geraldine A O'Hara; Christopher J A Duncan; Judith E Epstein; Nick J Edwards; Anja Scholzen; André J A M van der Ven; Cornelus C Hermsen; Adrian V S Hill; Robert W Sauerwein
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

7.  NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.

Authors:  Anne C Teirlinck; Meta Roestenberg; Marga van de Vegte-Bolmer; Anja Scholzen; Moniek J L Heinrichs; Rianne Siebelink-Stoter; Wouter Graumans; Geert-Jan van Gemert; Karina Teelen; Martijn W Vos; Krystelle Nganou-Makamdop; Steffen Borrmann; Yolanda P A Rozier; Marianne A A Erkens; Adrian J F Luty; Cornelus C Hermsen; B Kim Lee Sim; Lisette van Lieshout; Stephen L Hoffman; Leo G Visser; Robert W Sauerwein
Journal:  J Infect Dis       Date:  2012-11-27       Impact factor: 5.226

8.  Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.

Authors:  Matthew B Laurens; Peter Billingsley; Adam Richman; Abraham G Eappen; Matthew Adams; Tao Li; Sumana Chakravarty; Anusha Gunasekera; Christopher G Jacob; B Kim Lee Sim; Robert Edelman; Christopher V Plowe; Stephen L Hoffman; Kirsten E Lyke
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

Review 9.  Malaria vaccine: a future hope to curtail the global malaria burden.

Authors:  Kaliyaperumal Karunamoorthi
Journal:  Int J Prev Med       Date:  2014-05

10.  Immune selection suppresses the emergence of drug resistance in malaria parasites but facilitates its spread.

Authors:  Alexander O B Whitlock; Jonathan J Juliano; Nicole Mideo
Journal:  PLoS Comput Biol       Date:  2021-07-19       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.